Synthesis of G0 aminopolyol and aminosugar dendrimers, controlled by NMR and MALDI TOF mass spectrometry

References

• Uchegbu IF, Schatzlein AG, editors. Polymers in drug delivery. I editon. Boca Raton, FL: CRC Press; 2006. p. 199–236.10.1201/9781420021677
   Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res. 1986;46:6387–6392. PMID: 2946403.
   PubMed Web of Science ®Google Scholar
• Teow HM, Zhou Z, Najlah M, et al. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. Int. J. Pharm. 2013;441:701–711. doi:10.1016/j.ijpharm.2012.10.024.
   PubMed Web of Science ®Google Scholar
• Najlah M, D’Emanuele A. Crossing cellular barriers using dendrimer nanotechnologies. Curr. Opin. Pharmacol. 2006;6:522–527. doi:10.1016/j.coph.2006.05.004.
   PubMed Web of Science ®Google Scholar
• Medina SH, El-Sayed ME. Dendrimers as carriers for delivery of chemotherapeutic agents. Chem. Rev. 2009;109:3141–3157. doi:10.1021/cr900174j.
   PubMed Web of Science ®Google Scholar
• Skwarczynski M, Zaman M, Urbani CN, et al. Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system. Angew. Chem. Int. Ed. 2010;49:5742–5745. doi:10.1002/anie.201002221.
   PubMed Web of Science ®Google Scholar
• Baigude H, Katsuraya K, Okuyama K, et al. Synthesis of structurally-controlled AIDS vaccine model with glyco-peptide dendrimer scaffolds. Macromol. Chem. Phys. 2004;205:684–691. doi:10.1002/macp.200300097.
   Web of Science ®Google Scholar
• Xu H, Regino CAS, Koyama Y, et al. Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. Bioconjugate Chem. 2007;18:1474–1482.10.1021/bc0701085
   PubMed Web of Science ®Google Scholar
• Delort E, Darbre T, Reymond J-L. A strong positive dendritic effect in a peptide dendrimer-catalyzed ester hydrolysis reaction. J. Am. Chem. Soc. 2004;126:15642–15643.10.1021/ja044652p
   PubMed Web of Science ®Google Scholar
• Yu J, Rajanbabu TV, Parquette JR. Conformationally driven asymmetric induction of a catalytic dendrimer. J. Am. Chem. Soc. 2008;130:7845–7847. doi:10.1021/ja802308a.
   PubMed Web of Science ®Google Scholar
• Diallo MS, Arasho W, Johnson JH, et al. Dendritic chelating agents. 2. U(VI) binding to poly(amidoamine) and poly(propyleneimine) dendrimers in aqueous solutions. Environ. Sci. Technol. 2008;42:1572–1579.10.1021/es0715905
   PubMed Web of Science ®Google Scholar
• Klementieva O, Benseny-Cases N, Gella A, et al. Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in alzheimer’s disease. Amyloid–dendrimer aggregates morphology and cell toxicity. Biomacromolecules. 2011;12:3903–3909. doi:10.1021/bm2008636.
   PubMed Web of Science ®Google Scholar
• Pospisil M, Vannucci L, Fiserova A, et al. Glycodendrimeric ligands of c-type lectin receptors as therapeutic agents in experimental cancer. Adv. Exp. Med. Biol. 2001;495:343–347.10.1007/978-1-4615-0685-0
   PubMed Web of Science ®Google Scholar
• Albertazzi L, Serresi M, Albanese A, et al. Dendrimer internalization and intracellular trafficking in living cells. Mol. Pharm. 2010;7:680–688. doi:10.1021/mp9002464.
   PubMed Web of Science ®Google Scholar
• Niederhafner P, Sebestik J, Jezek J. Glycopeptide dendrimers. Part I. J. Pept. Sci. 2008;14:2–43.10.1002/(ISSN)1099-1387
   PubMed Web of Science ®Google Scholar
• Niederhafner P, Sebestik J, Jezek J. Glycopeptide dendrimers. Part II. J. Pept. Sci. 2008;14:44–65.10.1002/(ISSN)1099-1387
   PubMed Web of Science ®Google Scholar
• Niederhafner P, Reinis M, Sebestik J, et al. Glycopeptide dendrimers, part III: a review. Use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases. J. Pept. Sci. 2008;14:556–587. doi:10.1002/psc.1011.
   PubMed Web of Science ®Google Scholar
• Aoi K, Itoh K, Okada M. Globular carbohydrate macromolecules “Sugar Balls”. 1. Synthesis of novel sugar-persubstituted poly(amido amine) dendrimers. Macromolecules. 1995;28:5391–5393. doi:10.1021/ma00119a037.
   Web of Science ®Google Scholar
• Gajbhiye V, Palanirajan VK, Tekade RK, et al. Dendrimers as therapeutic agents: a systematic review. J. Pharm. Pharmacol. 2009;61:989–1003. doi:10.1211/jpp/61.08.0002.
   PubMed Web of Science ®Google Scholar
• Mishra MK, Kotta K, Hali M, et al. PAMAM dendrimer–azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infections. Bioorg. Med. Chem. Lett. 2011;7:935–944. doi:10.1016/j.nano.2011.04.008.
   Web of Science ®Google Scholar
• Schlick KH, Morgan JR, Weiel JJ, et al. Clusters of ligands on dendrimer surfaces. Bioorg. Med. Chem. Lett. 2011;21:5078–5083. doi:10.1016/j.bmcl.2011.03.100.
   PubMed Web of Science ®Google Scholar
• Bosnjakovic A, Mishra MK, Ren W, et al. Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation. Nanomedicine. 2011;7:284–294. doi:10.1016/j.nano.2010.10.008.
   PubMed Web of Science ®Google Scholar
• Rico-Lattes I, Blanzat M, Franceschi-Messant S, et al. Catanionic sugar derived surfactants, polymers and dendrimers: from molecules to targeted self-organized systems C. R. Chim. 2005;8:807–814. doi:10.1016/j.crci.2005.02.015.
   Web of Science ®Google Scholar